Your World of Legal Intelligence
 United Kingdom | +44 (0) 20 7284 8080

Barclays appoints Amit Tyagi as a Managing Director in Healthcare Investment Banking.

Document Cited in Related
Vincent

ENPNewswire-September 16, 2021--Barclays appoints Amit Tyagi as a Managing Director in Healthcare Investment Banking

(C)2021 ENPublishing - http://www.enpublishing.co.uk

Release date- 14092021 - Barclays announces the appointment of Amit Tyagi as a Managing Director in Healthcare Investment Banking.

Mr. Tyagi will be based in New York, and will focus on the Tools and Diagnostics sector.

He will report to Rick Landgarten, Global Head of Healthcare & Real Estate Groups at Barclays.

Mr. Tyagi joins Barclays with over 20 years of industry experience, most recently as Head of Healthcare at Huatai Securities. Prior to joining Huatai Securities in 2018, Mr. Tyagi was Global Head of Medical Diagnostics and Life Sciences Tools at UBS. Before joining UBS in 2008, he worked as a senior project manager at Medline Industries. Mr. Tyagi has led the origination and execution of a number of high-profile transactions during his career. These include advising Genstar Capital on its acquisition of Symmetry Medical's OEM, advising Asahi Kasei on its acquisition of Zoll Medical, advising Zonare Medical Systems on the company's sale to Mindray, and advising QuantaLife on its sale to Bio-Rad.

'Amit is an outstanding addition to our Healthcare team, and his extensive industry knowledge and transaction experience will further strengthen our ability to provide a superior value proposition to our clients,' said Rick Landgarten, Global Head of Healthcare & Real Estate...

To continue reading

Request your trial
COPYRIGHT Normans Media Ltd.

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT